Article Details

EDSA: Secures CAD$14 Million for COVID-19 Trial of EB05…

Retrieved on: 2021-02-17 15:09:42

Tags for this article:

Click the tags to see associated articles and topics

EDSA: Secures CAD$14 Million for COVID-19 Trial of EB05…. View article details on HISWAI: http://scr.zacks.com/News/Press-Releases/Press-Release-Details/2021/EDSA-Secures-CAD14-Million-for-COVID-19-Trial-of-EB05-article/default.aspx

Excerpt

EB05 is a monoclonal antibody that targets toll-like receptor 4 (TLR4). ... Domitrovic 2018: TLR4 monoclonal antibodies were evaluated both in vitro ...

Article found on: scr.zacks.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up